Swiss National Bank’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.8M Buy
260,500
+5,800
+2% +$56K ﹤0.01% 1588
2026
Q1
$1.89M Hold
254,700
﹤0.01% 1876
2025
Q4
$3M Buy
254,700
+5,200
+2% +$56.1K ﹤0.01% 1650
2025
Q3
$1.93M Buy
249,500
+3,700
+2% +$25.9K ﹤0.01% 1869
2025
Q2
$1.8M Sell
245,800
-2,900
-1% -$23.4K ﹤0.01% 1864
2025
Q1
$2.36M Sell
248,700
-3,400
-1% -$42.5K ﹤0.01% 1658
2024
Q4
$4.15M Buy
252,100
+2,600
+1% +$40.4K ﹤0.01% 1444
2024
Q3
$3.68M Sell
249,500
-1,900
-0.8% -$29.7K ﹤0.01% 1500
2024
Q2
$3.49M Hold
251,400
﹤0.01% 1502
2024
Q1
$3.95M Hold
251,400
﹤0.01% 1440
2023
Q4
$4.07M Sell
251,400
-29,000
-10% -$475K ﹤0.01% 1417
2023
Q3
$3.45M Buy
280,400
+2,700
+1% +$40.1K ﹤0.01% 1508
2023
Q2
$4.46M Buy
277,700
+18,800
+7% +$310K ﹤0.01% 1376
2023
Q1
$4.51M Sell
258,900
-29,600
-10% -$422K ﹤0.01% 1341
2022
Q4
$2.67M Buy
288,500
+7,500
+3% +$69.9K ﹤0.01% 1706
2022
Q3
$2.42M Buy
281,000
+4,500
+2% +$44.7K ﹤0.01% 1735
2022
Q2
$2.25M Hold
276,500
﹤0.01% 1822
2022
Q1
$3.36M Buy
276,500
+19,700
+8% +$415K ﹤0.01% 1711
2021
Q4
$8.76M Buy
256,800
+9,200
+4% +$360K 0.01% 1088
2021
Q3
$11.9M Buy
247,600
+2,700
+1% +$125K 0.01% 910
2021
Q2
$11.1M Buy
244,900
+3,900
+2% +$173K 0.01% 960
2021
Q1
$11.6M Buy
241,000
+3,800
+2% +$198K 0.01% 913
2020
Q4
$12.8M Buy
237,200
+900
+0.4% +$40.7K 0.01% 807
2020
Q3
$8.72M Buy
236,300
+14,900
+7% +$554K 0.01% 863
2020
Q2
$6.86M Buy
221,400
+29,000
+15% +$804K 0.01% 970
2020
Q1
$5.31M Buy
192,400
+3,500
+2% +$105K 0.01% 902
2019
Q4
$5.53M Buy
188,900
+5,800
+3% +$138K 0.01% 1090
2019
Q3
$3.5M Buy
183,100
+15,900
+10% +$373K ﹤0.01% 1317
2019
Q2
$3.67M Buy
167,200
+3,700
+2% +$81.2K ﹤0.01% 1314
2019
Q1
$3.35M Buy
163,500
+4,200
+3% +$73K ﹤0.01% 1340
2018
Q4
$2.01M Buy
159,300
+33,300
+26% +$496K ﹤0.01% 1567
2018
Q3
$1.93M Buy
126,000
+22,200
+21% +$307K ﹤0.01% 1739
2018
Q2
$1.36M Hold
103,800
﹤0.01% 1973
2018
Q1
$847K Buy
103,800
+5,700
+6% +$46.2K ﹤0.01% 2168
2017
Q4
$869K Hold
98,100
﹤0.01% 2165
2017
Q3
$1.09M Hold
98,100
﹤0.01% 2006
2017
Q2
$879K Sell
98,100
-23,600
-19% -$187K ﹤0.01% 2136
2017
Q1
$960K Hold
121,700
﹤0.01% 2063
2016
Q4
$1.04M Buy
121,700
+9,000
+8% +$77.1K ﹤0.01% 2007
2016
Q3
$926K Buy
112,700
+17,300
+18% +$145K ﹤0.01% 2013
2016
Q2
$767K Buy
+95,400
New +$765K ﹤0.01% 2118

Other funds holding NEO

Swiss National Bank's NEO Position: Q2 2026 in Review

Swiss National Bank increased its NeoGenomics (NEO) stake by 2.3% in Q2 2026, buying an estimated $56K and bringing the position to 260,500 shares worth $3.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1588.

Swiss National Bank first reported a position in NEO in Q2 2016 and has held it in 41 quarters since. The position peaked at $12.8M in Q4 2020. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Swiss National Bank held 260,500 shares of NeoGenomics worth $3.8M as of Q2 2026.
  • Swiss National Bank bought 5,800 NeoGenomics shares in Q2 2026, an estimated $56K.
  • NeoGenomics made up ﹤0.01% of Swiss National Bank's portfolio in Q2 2026, its #1588 holding.
  • Swiss National Bank first reported a position in NeoGenomics in Q2 2016 and has held it in 41 quarters since.
  • Swiss National Bank's NeoGenomics position peaked at $12.8M in Q4 2020.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.